Product information and disease descriptionPlace of product in therapy
Approaches to treatment
26 evidence topics · 16 sources
Ongoing post-approval monitoring
Not applicable.
SL1009 (sodium dichloroacetate)
Pyruvate dehydrogenase complex deficiency
- Manufacturer
- Saol Therapeutics
- Regulatory submission
- NDA resubmitted June 2026
- Launch
- Not announced
- Last updated